secwatch.observer — SEC 8-K summary
======================================

Issuer:     Journey Medical Corp (DERM)
CIK:        0001867066
Form:       8-K
Filed at:   2024-06-25T23:59:59+00:00
Accession:  0001104659-24-074743
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Journey Medical shareholders approve 3M share increase and 10-year extension of 2015 stock plan
--------------------------------------------------------------------------------

- Stockholders approved an amendment to the 2015 Stock Incentive Plan adding 3,000,000 shares, for a total of 10,642,857 shares authorized.
- Plan expiration extended by 10 years to May 27, 2035.
- All five director nominees re-elected; KPMG LLP ratified as auditor for 2024.
- Proposals received strong support: ~95% of votes cast for plan amendment, 99.9% for auditor ratification.
- The plan amendment became effective immediately upon stockholder approval on June 25, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1867066/000110465924074743/0001104659-24-074743-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1867066/000110465924074743/tm2418215d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-074743

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer